Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine

Toxins (Basel). 2022 Sep 20;14(10):651. doi: 10.3390/toxins14100651.

Abstract

Mycotoxin contamination of foodstuffs is a health concern worldwide and monitoring human exposure to mycotoxins is a key concern. Most mycotoxins and their metabolites are excreted in urine, but a reliable detection method is required, considering the low levels present in this biological sample. The aim of this work is to validate a sensitive methodology capable of simultaneously determining ten targeted mycotoxins as well as detecting untargeted ones by using Liquid Chromatography coupled to Quadrupole Time of Flight Mass Spectrometry (LC-Q-TOF-MS). The targeted mycotoxins were: enniatin A, B, A1, and B1, beauvericine, aflatoxin B1, B2, G1 and G2, and ochratoxin A. Several extraction procedures such as liquid-liquid extraction, dilute and shoot, and QuEChERS were assessed. Finally, a modified simple QuEChERS extraction method was selected. Creatinine adjustment and matrix-matched calibration curves are required. The limit of detection and limit of quantification values ranged from 0.1 to 1.5 and from 0.3 to 5 ng/mL, respectively. Recoveries achieved were higher than 65% for all mycotoxins. Later, the method was applied to 100 samples of women's urine to confirm the applicability and determine their internal exposure. The untargeted mycotoxins most found were trichothecenes, zearalenones, and ochratoxins.

Keywords: biomonitoring; mycotoxins; simple extraction; untargeted; women urine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aflatoxin B1 / analysis
  • Biomarkers / urine
  • Chromatography, High Pressure Liquid / methods
  • Chromatography, Liquid / methods
  • Creatinine
  • Female
  • Humans
  • Mycotoxins* / analysis
  • Ochratoxins* / analysis
  • Tandem Mass Spectrometry / methods
  • Trichothecenes* / analysis

Substances

  • Mycotoxins
  • Ochratoxins
  • Aflatoxin B1
  • Creatinine
  • Trichothecenes
  • Biomarkers

Grants and funding

This research was funded by Generalitat Valenciana (GV/2021/111), Ministry of Universities (CAS21/00008 and NextGeneration EU), Instituto de Salud Carlos III (FIS-FEDER: 13/1944, 16/1288, 17/00663 and 19/1338; FIS-FSE: 17/00260; Miguel Servet-FSE: MSII20/0006).